4.5 Article

3D Printing of Calcium Phosphate Ceramics for Bone Tissue Engineering and Drug Delivery

Journal

ANNALS OF BIOMEDICAL ENGINEERING
Volume 45, Issue 1, Pages 23-44

Publisher

SPRINGER
DOI: 10.1007/s10439-016-1678-3

Keywords

3D printing; Vat polymerization; Powder bed fusion; Material extrusion; Binder jetting; Bone; Tissue engineering; Drug delivery

Funding

  1. AO Trauma Research Institute - Clinical Priority Program on Bone Infection
  2. National Institutes of Health [NIH P30 AR061307, R34 DE025573]
  3. Whitaker International Program post-doctoral scholarship
  4. National Science Foundation graduate research fellowship (NSF Award) [DGE-1419118]
  5. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069655, P30AR061307] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R34DE025573] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Additive manufacturing, also known as 3D printing, has emerged over the past 3 decades as a disruptive technology for rapid prototyping and manufacturing. Vat polymerization, powder bed fusion, material extrusion, and binder jetting are distinct technologies of additive manufacturing, which have been used in a wide variety of fields, including biomedical research and tissue engineering. The ability to print biocompatible, patient-specific geometries with controlled macro- and micro-pores, and to incorporate cells, drugs and proteins has made 3D-printing ideal for orthopaedic applications, such as bone grafting. Herein, we performed a systematic review examining the fabrication of calcium phosphate (CaP) ceramics by 3D printing, their biocompatibility in vitro, and their bone regenerative potential in vivo, as well as their use in localized delivery of bioactive molecules or cells. Understanding the advantages and limitations of the different 3D printing approaches, CaP materials, and bioactive additives through critical evaluation of in vitro and in vivo evidence of efficacy is essential for developing new classes of bone graft substitutes that can perform as well as autografts and allografts or even surpass the performance of these clinical standards.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available